Patient Care: Chronic Disease Management and MTM in Ambulatory Care
What to master
Patient care items center on chronic-disease management and medication therapy management (MTM) in the clinic setting. Know guideline-based targets and the monitoring that accompanies them: blood pressure goals per ACC/AHA (<130/80 for most, individualized in frailty or orthostasis), individualized A1c targets (commonly <7% for most adults, <8% with limited life expectancy or hypoglycemia risk), statin intensity by ASCVD risk, inhaler step therapy in asthma and COPD, guideline-directed medical therapy for heart failure with reduced ejection fraction, and renal dosing or eligibility criteria for DOACs, metformin, and SGLT2 inhibitors. Be able to interpret labs (SCr/eGFR, potassium, A1c, TSH, INR, CBC), screen for drug interactions and duplicate therapy, and document in SOAP format with a defensible assessment and plan.
Traps
Questions often hinge on the difference between a population target and a defensible individualized target; between a screening recommendation and a treatment threshold; and between "start" and "titrate." Distractors frequently ignore renal function, potassium, or pregnancy status. Insulin and corticosteroid conversions and sliding-scale correction are recurring calculation traps.
Worked example
A 64-year-old with type 2 diabetes on metformin, A1c 8.9%, eGFR 52 mL/min/1.73 m², and established ASCVD. The next step is not reflexive addition of a sulfonylurea; it is adding an agent with proven cardiovascular and kidney benefit (SGLT2 inhibitor or GLP-1 receptor agonist), then rechecking A1c in about 3 months. Rule of thumb: match therapy to comorbidities first, then to the A1c number.